Application 040686
- Type
- ANDA
- Sponsor
- AKORN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ETHOSUXIMIDE | ETHOSUXIMIDE | CAPSULE;ORAL | 250MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 61748-025 | Ethosuximide | Ethosuximide | VersaPharm Inc. - an Akorn Company | ANDA | Current |
| 61748-025 | Ethosuximide | Ethosuximide | Akorn | ANDA | Current |
| 61748-025 | Ethosuximide | Ethosuximide | Versapharm Incorporated | ANDA | Current |
| 61748-025 | Ethosuximide | Ethosuximide | Versapharm Incorporated | ANDA | Current |